BlueYard Capital
Edit

BlueYard Capital

https://www.blueyard.com
Last activity: 16.09.2026
Active
BlueYard backs founders building the interconnected elements that can become the fabric of our future.
Portfolio
9
Mentions
67
Investment Type: Venture Capital

Portfolio 9

DateNameWebsiteTotal RaisedLocation
22.07.2026Transcript...transcriptabio.com$24MUnited Sta...
22.10.2025Chemifychemify.io$97.62MUnited Kin...
06.10.2025Aerskaaerska.com$79.94MIreland
26.09.2025Corintis S...corintis.com$49MSwitzerlan...
18.07.2023Tromero Lt...tromero.org$2MUnited Kin...
17.07.2023Rapidatarapidata.ai$10.25MSwitzerlan...
06.04.2023Sensible B...sensible.bio$4.2MUnited Kin...
11.01.2023Visolisvisolisbio.com$10.86MUnited Sta...
07.04.2016deepstream...deepstreamhub.com$1MGermany, B...

Mentions in press and media 67

DateTitleDescription
16.09.2026Boxd raises $2M to build cloud infrastructure for AI coding agentsDutch startup Boxd has raised $2 million in a pre-seed funding round to develop its cloud computing infrastructure for developers and AI coding agents. The round was led by BlueYard Capital, with participation from OVNI Capital, Antler, S20...
15.09.2026Boxd raises $2M to build cloud infrastructure for AI coding agentsDutch startup Boxd has raised $2 million in a pre-seed funding round to develop its cloud computing infrastructure for developers and AI coding agents. The round was led by BlueYard Capital, with participation from OVNI Capital, Antler, S20...
27.07.2026Transcripta Bio Secures $24 Million to Accelerate AI Drug Discovery for Neurological DiseasesTranscripta Bio announced a significant $24 million capital raise. This funding, secured since its Series A, propels the company's AI-driven drug discovery platform. The Palo Alto firm targets neurological and neuromuscular diseases. New ca...
22.07.2026Transcripta Bio Raises $24 Million To Advance AI-Powered Neurological Drug PipelineTranscripta Bio has raised $24 million since its Series A financing to advance an AI-powered drug discovery platform focused on neurological and neuromuscular diseases. New investors Mayo Clinic and Omnimed joined existing backers JAZZ Vent...
22.07.2026Transcripta Bio Announces $24 Million Funding PALO ALTO, CA, Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular diseases, announced it has raised $24 million since its Series A. >> Click here for more funding data on Transcripta Bio &...
22.02.2026Rapidata: $8.5 Million Seed Funding Closed For Scaling Global Human Feedback NetworkRapidata announced it has raised an $8.5 million seed round to accelerate AI development by scaling on-demand human feedback for model training and evaluation. The round was co-led by Canaan Partners and IA Ventures, with participation from...
21.02.2026Rapidata Secures $8.5M, Unleashing AI's Feedback LoopZurich AI innovator Rapidata secured $8.5 million in Seed capital. This funding empowers its global human feedback network. Rapidata solves AI's critical bottleneck: slow human judgment. AI models require rapid, precise validation. The comp...
20.02.2026Zurich-based AI infrastructure startup Rapidata raises €7.2 million to scale global human feedback networkRapidata, a Swiss company that accelerates AI development through scalable, on-demand data labeling via digital ads, announced a €7.2 million ($8.5 million) Seed round to scale their global human data network and support growing demand from...
20.02.2026Rapidata raised USD 8.5 million to eliminate the feedback bottleneck in AI development As AI development accelerates, access to timely human feedback has emerged as a critical bottleneck. While compute and model architectures have advanced rapidly, collecting high-quality human judgments, preferences, and validation data rem...
19.02.2026Rapidata raises USD 8.5M to accelerate AI developmentRapidata, a Venture Leaders program participant and Venture Kick winner, is tackling one of AI development’s biggest bottlenecks: the slow, manual process of gathering large-scale human feedback. By leveraging crowd intelligence and a globa...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In